Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glatiramer Acetate and N-Acetylcysteine in RR-MS
NCT00203099Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of acetylcysteine in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2004; status: completed.
02
Drugs
acetylcysteine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00203099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203099.